1,1-Difluoroethyl-substituted triazolothienopyrimidines as inhibitors of a human urea transport protein (UT-B): new analogs and binding model

Bioorg Med Chem Lett. 2013 Jun 1;23(11):3338-41. doi: 10.1016/j.bmcl.2013.03.089. Epub 2013 Apr 1.

Abstract

The kidney urea transport protein UT-B is an attractive target for the development of small-molecule inhibitors with a novel diuretic ('urearetic') action. Previously, two compounds in the triazolothienopyrimidine scaffold (1a and 1c) were reported as UT-B inhibitors. Compound 1c incorporates a 1,1-difluoroethyl group, which affords improved microsomal stability when compared to the corresponding ethyl-substituted compound 1a. Here, a small focused library (4a-4f) was developed around lead inhibitor 1c to investigate the requirement of an amidine-linked thiophene in the inhibitor scaffold. Two compounds (4a and 4b) with nanomolar inhibitory potency (IC50≈40 nM) were synthesized. Computational docking of lead structure 1c and 4a-4f into a homology model of the UT-B cytoplasmic surface suggested binding with the core heterocycle buried deep into the hydrophobic pore region of the protein.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Binding Sites
  • Fluorine / chemistry*
  • Humans
  • Membrane Transport Proteins / chemistry*
  • Membrane Transport Proteins / metabolism
  • Microsomes / metabolism
  • Molecular Docking Simulation
  • Protein Binding
  • Protein Structure, Tertiary
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry*
  • Pyrimidines / metabolism
  • Structure-Activity Relationship
  • Urea Transporters

Substances

  • Membrane Transport Proteins
  • Pyrimidines
  • Fluorine